ArticleFrontiers in pharmacology2022

Real-world safety of PCSK9 inhibitors: A pharmacovigilance study based on spontaneous reports in FAERS.

Zhen Feng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.